Charles N. Serhan, PhD, DSc

Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School, Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine
  • SAB

He is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital and Co-Director of the Brigham Research Institute. Charles received a Bachelor of Science in biochemistry from Stony Brook University followed by a Doctorate in experimental pathology and medical sciences from New York University School of Medicine. He was a visiting scientist and postdoctoral fellow at the Karolinska Institutet, Stockholm with Professor Bengt Samuelsson (Nobel Laurate Medicine 82). In 1987, he joined the faculty at Harvard Medical School and in 1996 received the honorary degree from Harvard University.

Prof. Serhan has experience leading multidisciplinary research teams as PI/PD for several NIH supported Program Project Grants and a P-50 Center Grant. He is currently Program Director of the Program Project entitled “Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology” (P01-GM095467).

He received several research awards including an NIH MERIT and recent international awards: 2016 Ross Prize in Molecular Medicine, International Eicosanoid Research Foundation’s 2017 Lifetime Achievement Award, the American Society of Investigative Pathology 2018 Rous Whipple Award and the 2018 British Pharmacology Society’s Gaddum International Prize and Award Lecture. 2019 Honorary Lifetime Award, Society for Leukocyte Biology, for excellence in leukocyte biology research.

His h-index is 172 in google scholar.